Trang chủSUNPHARMA • NSE
add
Công ty Sun Pharmaceutical Industries
Giá đóng cửa hôm trước
1.688,80 ₹
Mức chênh lệch một ngày
1.679,30 ₹ - 1.695,00 ₹
Phạm vi một năm
1.460,90 ₹ - 1.960,35 ₹
Giá trị vốn hóa thị trường
4,06 NT INR
Số lượng trung bình
2,82 Tr
Tỷ số P/E
35,87
Tỷ lệ cổ tức
0,95%
Sàn giao dịch chính
NSE
Tin tức liên quan đến cổ phiếu
Giới thiệu
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world.
Around 70% of Sun Pharma’s revenue is generated from international markets. The US and India are the largest markets, accounting for over 60% of the company's turnover. Manufacturing is across 43 locations in India, the US, Asia, Africa, Australia and Europe. The products cater to therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin. Wikipedia
Ngày thành lập
1983
Trụ sở chính
Trang web
Nhân viên
43.000